Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7752388 | 0.98 | ALDH1A1 (0.33) | ALDH1A1CYP3A4 | |
| SCHEMBL7752393 | 0.94 | ALDH1A1 (0.34) | ALDH1A1CYP3A4 | |
| SCHEMBL17813310 | 0.83 | — | — | |
| SCHEMBL8987982 | 0.83 | ALDH1A1 (0.32) | ALDH1A1CYP3A4 | |
| SCHEMBL8739288 | 0.82 | ALDH1A1 (0.33) | ALDH1A1CYP3A4 | |
| SCHEMBL21147091 | 0.82 | ALDH1A1 (0.33) | ALDH1A1CYP3A4 | |
| SCHEMBL19217559 | 0.82 | ALDH1A1 (0.33) | ALDH1A1CYP3A4 | |
| SCHEMBL20604028 | 0.82 | ALDH1A1 (0.33) | ALDH1A1CYP3A4 | |
| SCHEMBL8739143 | 0.82 | ALDH1A1 (0.33) | ALDH1A1CYP3A4 | |
| SCHEMBL18473954 | 0.82 | ALDH1A1 (0.33) | ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023008572-A1 | ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR | 広栄化学株式会社 | 2023-02-02 | — | — | WO | disclosed |
| WO-2022260057-A1 | CURABLE COMPOSITION | モメンティブ・パフォーマンス・マテリアルズ・ジャパン合同会社 | 2022-12-15 | — | — | WO | disclosed |
| EP-3412727-B1 | AQUEOUS DISPERSION, METHOD FOR MANUFACTURING THE SAME, AND IMAGE FORMING METHOD | FUJIFILM CORP (JP) | 2021-12-08 | — | — | EP | disclosed |
| WO-2021221084-A1 | BLOCKED ISOCYANATE COMPOSITION, HEAT-CURABLE RESIN COMPOSITION, CURED PRODUCT, PRODUCTION METHOD THEREFOR, AMIDATE COMPOUND, AND CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES | 広栄化学株式会社 | 2021-11-04 | — | — | WO | disclosed |
| WO-2020078939-A1 | DIELECTRIC COPOLYMER MATERIALS | MERCK PATENT GMBH (DE) | 2020-04-23 | — | — | WO | disclosed |
| WO-2020078938-A1 | DIELECTRIC COPOLYMER MATERIALS | MERCK PATENT GMBH (DE) | 2020-04-23 | — | — | WO | disclosed |
| WO-2019141833-A1 | DIELECTRIC MATERIALS | MERCK PATENT GMBH (DE) | 2019-07-25 | — | — | WO | disclosed |
| US-20180217498-A1 | PHOTOACTIVABLE NITROGEN BASES | BASF SE (DE) | 2018-08-02 | — | — | US | disclosed |
| US-20180201879-A1 | CLEANING PRODUCT | THE PROCTER & GAMBLE COMPANY | 2018-07-19 | — | — | US | disclosed |
| WO-2018099827-A1 | AQUEOUS DISPERSION OF POLYALKENE SUPRAMOLECULAR POLYMER AND ITS USE IN COSMETICS | L'OREAL (FR) | 2018-06-07 | — | — | WO | disclosed |
| US-7790926-B2 | Alpha, omega-difunctional aldaramides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-09-07 | — | — | US | disclosed |
| EP-2189151-A1 | Process for the makeup of skin and/or lips by applying a composition comprising a supramolecular polymer | L'OREAL (FR) | 2010-05-26 | — | — | EP | disclosed |
| US-20100105794-A1 | PHOTOACTIVABLE NITROGEN BASES | CIBA CORPORATION (US) | 2010-04-29 | — | — | US | disclosed |
| EP-1572809-B2 | METHOD FOR THE PRODUCTION OF PHTHALOCYANINE PIGMENT PREPARATIONS | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2009-11-18 | — | — | EP | disclosed |
| US-7459016-B2 | Method for the production of phthalocyanine pigment preparations | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2008-12-02 | — | — | US | disclosed |
| EP-1797867-A1 | Cosmetic or pharmaceutical composition comprising a copolymer containing at least one ionisable group, and cosmetic treatment | L'Oréal (FR) | 2007-06-20 | — | — | EP | disclosed |
| US-6297401-B1 | A 3-NITROSALICYLAMIDE DERIVATIVE EFFECTIVE AGAINST PLANT PYTOPATHOGENS | DOW AGROSCIENCES LLC | 2001-10-02 | — | — | US | disclosed |
| EP-1035772-A4 | FUNGICIDAL COMPOSITIONS AND METHODS, AND COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF | DOW AGROSCIENCES LLC (US) | 2001-03-28 | — | — | EP | disclosed |
| EP-1035772-A1 | FUNGICIDAL COMPOSITIONS AND METHODS, AND COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF | Dow AgroSciences LLC (US) | 2000-09-20 | — | — | EP | disclosed |
| WO-1999027783-A1 | FUNGICIDAL COMPOSITIONS AND METHODS, AND COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF | DOW AGROSCIENCES LLC (US) | 1999-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180217498-A1 | PHOTOACTIVABLE NITROGEN BASES | CBR1, NR0B1, NR0B2 | ALDH1A1 1733/4885CYP3A4 259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.